![](/img/cover-not-exists.png)
A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74âyears old and patients with PS 0 or 1 from 75âyears: NEJ039A (trial in progress)
Kaira, Kyoichi, Mouri, Atsuto, Kato, Shingo, Yoshimura, Kenichi, Kagamu, Hiroshi, Kobayashi, KunihikoVolume:
20
Journal:
BMC Cancer
DOI:
10.1186/s12885-020-07406-y
Date:
December, 2020
File:
PDF, 944 KB
2020